Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Episurf Medical ABEPSFF 42 3-1 Month Momentum % is N/A% as of Aug. 13, 2026. GuruFocus rates EPSFF with a GF Score™ of 42/100 and a GF Value™ of $0.14. The stock has 7 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Episurf Medical AB ranks worse than 90.15% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-13), Episurf Medical AB's 3-1 Month Momentum % is N/A%.
The industry rank for Episurf Medical AB's 3-1 Month Momentum % or its related term are showing as below:
EPSFF's 3-1 Month Momentum % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -6.59 * Ranked among companies with meaningful 3-1 Month Momentum % only.
Episurf Medical AB (OTCPK:EPSFF) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Episurf Medical AB 3-1 Month Momentum % Related Terms
EPSFF vs ABT, SYK, MDT: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, Episurf Medical AB's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Episurf Medical AB 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Episurf Medical AB's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Episurf Medical AB's 3-1 Month Momentum % falls into.
Episurf Medical AB (OTCPK:EPSFF) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Episurf Medical AB (EPSFF) has a 3-1 Month Momentum % of N/A% as of Aug. 13, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Episurf Medical AB and its competitors. According to the industry distribution chart, Episurf Medical AB ranks #769 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 90.2%.
Is Episurf Medical AB's 3-1 Month Momentum % too high?
Episurf Medical AB's current 3-1 Month Momentum % is N/A%. Based on the distribution chart, Episurf Medical AB ranks #769 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Episurf Medical AB has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Episurf Medical AB's 3-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Episurf Medical AB ranks #769 out of 853 companies for 3-1 Month Momentum %. This places Episurf Medical AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Episurf Medical AB and its competitors. Episurf Medical AB's current 3-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Episurf Medical AB stock overvalued right now?
Episurf Medical AB (EPSFF) has a current 3-1 Month Momentum % of N/A%. The stock's GF Value™ is $0.14, compared to a current price of $0.18 — trading 29.9% above its estimated fair value. The current 3-1 Month Momentum % is N/A%. Episurf Medical AB's overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Episurf Medical AB (EPSFF), the current 3-1 Month Momentum % is N/A% as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Episurf Medical AB (EPSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Episurf Medical AB stock appears to be overvalued.
The current stock price of $0.18 is trading 29.9% above its estimated GF Value™ of $0.14.
Key valuation signals for EPSFF:
3-1 Month Momentum %: N/A%
GF Value™: $0.14 vs. price of $0.18 (29.9% above fair value)
No single metric tells the full story. See the EPSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint. The company is forming a new strategic business segment through the acquisition of real estate assets.
42GF Score
Get the complete analysis for EPSFF
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EPSFF has been successfully added to your 
